| Literature DB >> 6384976 |
Abstract
New cytotoxic chemotherapeutic compounds under development or in early clinical trial which might be considered for clinical evaluation in prostatic carcinoma are discussed. The following classes of agents are considered: lipid-soluble antifolates, anthracyclines, nitrosoureas, and platinum analogues. A group of miscellaneous compounds is also discussed.Entities:
Mesh：
Substances：
Year: 1984 PMID： 6384976 DOI： 10.1002/pros.2990050504
Source DB: PubMed Journal: Prostate ISSN： 0270-4137 Impact factor: 4.104